Back

DANFLU-1 - High-dose vs. standard-dose quadrivalent influenza vaccine in elderly adults.

27 August 2022 (09:12 - 09:24)
Organised by:
Congress Presentation Part of: HOT LINE SESSION 2 Public Health ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Niklas Dyrby Johansen

Herlev and Gentofte Hospital, Copenhagen (Denmark)

12 More presentations in this session

Presentation thumbnail
DANCAVAS - Screening and intervention to prevent cardiovascular disease.
Professor A. Diederichsen (Odense, DK)
Slides Video
Presentation thumbnail
Discussant review - DANCAVAS.
Doctor H. Van Spall (Hamilton, CA)
Slides Video
Presentation thumbnail
Panel discussion - DANCAVAS.
Video
Presentation thumbnail
ADVOR - Acetazolamide in acute heart failure.
Professor W. Mullens (Genk, BE)
Slides Video
Presentation thumbnail
Discussant review - ADVOR.
Professor C. Mueller (Basel, CH)
Slides Video

Access the full session

Session thumbnail
HOT LINE SESSION 2
Video

The Event

Event poster

ESC Congress 2022

27 August 2022 09:12 CET
You may be interested in
thumbnail
Congress Presentation
Results from the largest ever individually randomised influenza vaccine effectiveness study
thumbnail
Congress Presentation
DANFLU-2: High-Dose vs. Standard-Dose Influenza Vaccine and Cardio-Respiratory Outcomes in Older Adults
thumbnail
Congress Presentation
DANFLU: using a pragmatic randomised trial to assess the relative effectiveness of influenza vaccine on severe cardio-respiratory outcomes in elderly adults

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources